Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide alone remains the evidence leader The strongest direct evidence is for retatrutide alone
Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial
Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health
Common, usually mild reactions Pain at the injection site is the single most reported complaint
US$ 24.69
US$ 28.60
US$ 26.81
US$ 28.20
US$ 20.34
US$ 22.80
US$ 19.98
US$ 20.50
US$ 27.10
US$ 27.07
US$ 22.55
US$ 27.16
US$ 26.17
